companydata.dkEUSA Pharma (Denmark) ApS: Financial statements 2021
CVR: 39055988
EUSA Pharma (Denmark) ApS (CVR 39055988) has filed annual accounts for 2021. In 2021, the company reported a gross profit of DKK 9,429,497 and a net result of DKK 482,679 compared with DKK 607,118 the year before. That is a decrease of 4.1% compared with the year before. Equity amounted to DKK 1,305,255. The solvency ratio was 75.3%. The company had 5 employees in the financial year.
- Gross Profit
- 9,429,497 kr.
- Profit/Loss
- 482,679 kr.
- Equity
- 1,305,255 kr.
- Total Assets
- 1,733,279 kr.
- Employees
- 5
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2021 | - | 9.4 mio. | 483 t. | 1.3 mio. | 5 |
| 2020 | - | 9.8 mio. | 607 t. | 823 t. | 6 |
| 2019 | - | 2.1 mio. | 228 t. | 215 t. | 3 |
Find more companies like EUSA Pharma (Denmark) ApS
Build lead lists with filters on industry, geography, size and financials — and export straight to Excel.
Try the lead list generatorEvents in 2021
EUSA Pharma (Denmark) ApS has published its annual report for 2020. Gross profit came to DKK 9,829,410, and the net result was DKK 607,118.
As of May 25, 2021, Frank Carsten Thiel is registered as director of EUSA Pharma (Denmark) ApS.
As of May 25, 2021, Lee Scot Morley has stepped down as director of EUSA Pharma (Denmark) ApS.
About EUSA Pharma (Denmark) ApS
EUSA Pharma (Denmark) ApS was a Danish company of the type Anpartsselskab based in Hellerup, founded in 2017 and dissolved in 2024. The company was registered under the industry Reklamebureauer. In 2023, the company reported a gross profit of DKK 1,928,889 and a net result of DKK 141,012 compared with DKK 198,473 the year before. Equity amounted to DKK 1,644,740.